NEW YORK, Dec. 21, 2020 (GLOBE NEWSWIRE) — Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”),…
Experienced Executives Will Add Strength to the Combined Company’s Strategy in Accelerating Growth NEW YORK, Dec. 14, 2020 (GLOBE NEWSWIRE)…
Clever Leaves expands global capabilities and development of market specific pharmaceutical products NEW YORK, Dec. 10, 2020 (GLOBE NEWSWIRE) — Clever…
NEW YORK, December 4, 2020 – Clever Leaves International Inc. (the “Company” or “Clever Leaves”) wishes to announce an amendment…
Clever Leaves Received an Initial $2M Payment Upon Signing the $4M “take or pay” Agreement NEW YORK, Nov. 23, 2020…
Company continues to successfully expand international partnerships, supply chain, and logistics operations NEW YORK, Nov. 18, 2020 (GLOBE NEWSWIRE) — Clever…
RYE BROOK, N.Y., Nov. 09, 2020 (GLOBE NEWSWIRE) — Schultze Special Purpose Acquisition Corp. (NASDAQ: SAMA, SAMAW, and SAMAU) (“SAMA”)…
Priority Status Highlights Government Support; Accelerates Execution of Strategic Projects and Regulatory Processes NEW YORK, Sept. 23, 2020 (GLOBE NEWSWIRE)…
La licencia marca el comienzo de las actividades de cultivo en Europa y establece a Portugal como el centro europeo de producción de cannabis medicinal de Clever Leaves
La licencia marca el comienzo de las actividades de cultivo en Europa y establece a Portugal como el centro europeo de producción de cannabis medicinal de Clever Leaves
The biggest question mark for the global CBD industry right now is not how to market the cannabinoid and what…